VAL — ValiRx Balance Sheet
0.000.00%
- £1.97m
- £1.01m
- £0.05m
- 12
- 23
- 36
- 10
Annual balance sheet for ValiRx, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.85 | 0.594 | 1.14 | 0.175 | 1.56 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.106 | 0.167 | 0.265 | 0.244 | 0.238 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.98 | 0.8 | 1.46 | 0.566 | 1.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.021 | 0.013 | 0.006 | 0.243 | 0.202 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 4.94 | 3.52 | 3.98 | 3.13 | 4.26 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.124 | 0.068 | 0.128 | 0.215 | 0.345 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.027 | -0.075 | -0.075 | -0.088 | -0.055 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.91 | 3.6 | 4.05 | 3.22 | 4.32 |
| Total Liabilities & Shareholders' Equity | 4.94 | 3.52 | 3.98 | 3.13 | 4.26 |
| Total Common Shares Outstanding |